[ Pobierz całość w formacie PDF ]
Leroux-Roels G, Quinaux E, Depla E, Dincq S, 40. Markowitz LE, Dunne EF, Saraiya M, Lawson HW,
Vander Stichele C, Maertens G, Hulstaert F. Chesson H, Unger ER. 2007. Quadrivalent human
2003. A pilot study of therapeutic vaccination with papillomavirus vaccine: Recommendations of the
envelope protein E1 in 35 patients with chronic Advisory Committee on Immunization Practices
hepatitis C. Hepatology 38:1289 1296. (ACIP). MMWR Recomm Rep 56:1 24.
29. Kueltzo LA, Ersoy B, Ralston JP, Middaugh CR. 41. Paavonen J, Jenkins D, Bosch FX, Naud P, Sal-
2003. Derivative absorbance spectroscopy and pro- meron J, Wheeler CM, Chow SN, Apter DL, Kitch-
tein phase diagrams as tools for comprehensive ener HC, Castellsague X, de Carvalho NS, Skinner
protein characterization: A bGCSF case study. SR, Harper DM, Hedrick JA, Jaisamrarn U, Limson
J Pharm Sci 92:1805 1820. GA, Dionne M, Quint W, Spiessens B, Peeters P,
30. Kueltzo LA, Middaugh CR. 2003. Structural char- Struyf F, Wieting SL, Lehtinen MO, Dubin G. 2007.
acterization of bovine granulocyte colony stimulat- Efficacy of a prophylactic adjuvanted bivalent L1
ing factor: Effect of temperature and pH. J Pharm virus-like-particle vaccine against infection with
Sci 92:1793 1804. human papillomavirus types 16 and 18 in young
31. Fan H, Ralston J, Dibiase M, Faulkner E, Mid- women: An interim analysis of a phase III double-
daugh CR. 2005. Solution behavior of IFN-beta- blind, randomised controlled trial. Lancet
1a: An empirical phase diagram based approach. 369:2161 2170.
J Pharm Sci 94:1893 1911. 42. Carmicle S, Steede NK, Landry SJ. 2007. Antigen
32. Thorson JA, Yu LW, Hsu AL, Shih NY, Graves PR, three-dimensional structure guides the processing
Tanner JW, Allen PM, Piwnica-Worms H, Shaw AS. and presentation of helper T-cell epitopes. Mol
1998. 14-3-3 proteins are required for maintenance Immunol 44:1159 1168.
of Raf-1 phosphorylation and kinase activity. Mol 43. Landry SJ. 2000. Helper T-cell epitope immunodo-
Cell Biol 18:5229 5238. minance associated with structurally stable seg-
33. Gonenne A, Ernst R. 1978. Solubilization of mem- ments of hen egg lysozyme and HIV gp120.
brane proteins by sulfobetaines, novel zwitterionic J Theor Biol 203:189 201.
surfactants. Anal Biochem 87:28 38. 44. Li P, Haque MA, Blum JS. 2002. Role of disulfide
34. Gasymov OK, Glasgow BJ. 2007. ANS fluorescence: bonds in regulating antigen processing and epitope
Potential to augment the identification of the exter- selection. J Immunol 169:2444 2450.
nal binding sites of proteins. Biochim Biophys Acta 45. Mirano-Bascos D, Tary-Lehmann M, Landry SJ.
1774:403 411. 2008. Antigen structure influences helper T-cell
35. Keck ZY, Sung VM, Perkins S, Rowe J, Paul S, epitope dominance in the human immune response
Liang TJ, Lai MM, Foung SK. 2004. Human mono- to HIV envelope glycoprotein gp120. Eur J Immunol
clonal antibody to hepatitis C virus E1 glycoprotein 38:1231 1237.
that blocks virus attachment and viral infectivity. 46. Park B, Lee S, Kim E, Cho K, Riddell SR, Cho S,
J Virol 78:7257 7263. Ahn K. 2006. Redox regulation facilitates optimal
36. Depla E, Maertens G, Bosman A, Wijnendaele FV. peptide selection by MHC class I during antigen
2003. Particles of HCV envelope proteins: Use for processing. Cell 127:369 382.
vaccination. US Patent 6635257. 47. Ausar SF, Foubert TR, Hudson MH, Vedvick TS,
37. Kim H, Lim K. 2003. Description of temperature Middaugh CR. 2006. Conformational stability and
dependence of critical micelle concentration. Bull disassembly of Norwalk virus-like particles. Effect
Korean Chem Soc 24:1449 1454. of pH and temperature. J Biol Chem 281:19478
38. Mast EE, Margolis HS, Fiore AE, Brink EW, Gold- 19488.
stein ST, Wang SA, Moyer LA, Bell BP, Alter MJ. 48. Kissmann J, Ausar SF, Foubert TR, Brock J, Swit-
2005. A comprehensive immunization strategy zer MH, Detzi EJ, Vedvick TS, Middaugh CR. 2008.
to eliminate transmission of hepatitis B virus Physical stabilization of Norwalk virus-like parti-
infection in the United States: Recommendations cles. J Pharm Sci 97:4208 4218.
of the Advisory Committee on Immunization Prac- 49. Kissmann J, Ausar SF, Rudolph A, Braun C, Cape
tices (ACIP). Part 1. Immunization of infants, chil- SP, Sievers RE, Federspiel MJ, Joshi SB, Middaugh
dren, and adolescents. MMWR Recomm Rep 54: CR. 2008. Stabilization of measles virus for vaccine
1 31. formulation. Hum Vaccin 4.
39. Vietheer PT, Boo I, Drummer HE, Netter HJ. 2007. 50. Salnikova MS, Middaugh CR, Rytting JH. 2008.
[ Pobierz całość w formacie PDF ]